Mirzaee Hooman, Ariens Emily, Blaskovich Mark A T, Clark Richard J, Schenk Peer M
Plant-Microbe Interactions Laboratory, School of Agriculture and Food Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Pharmaceuticals (Basel). 2021 Nov 27;14(12):1232. doi: 10.3390/ph14121232.
We hypothesized that environmental microbiomes contain a wide range of bacteria that produce yet uncharacterized antimicrobial compounds (AMCs) that can potentially be used to control pathogens. Over 600 bacterial strains were isolated from soil and food compost samples, and 68 biocontrol bacteria with antimicrobial activity were chosen for further studies based on inhibition assays against a wide range of food and plant pathogens. For further characterization of the bioactive compounds, a new method was established that used living pathogens in a liquid culture to stimulate bacteria to produce high amounts of AMCs in bacterial supernatants. A peptide gel electrophoresis microbial inhibition assay was used to concurrently achieve size separation of the antimicrobial peptides. Fifteen potential bioactive peptides were then further characterized by tandem MS, revealing cold-shock proteins and 50S ribosomal proteins. To identify non-peptidic AMCs, bacterial supernatants were analyzed by HPLC followed by GC/MS. Among the 14 identified bioactive compounds, 3-isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione and 2-acetyl-3-methyl-octahydropyrrolo[1,2-a]piperazine-1,4-dione were identified as new AMCs. Our work suggests that antimicrobial compound production in microbes is enhanced when faced with a threat from other microorganisms, and that this approach can rapidly lead to the development of new antimicrobials with the potential for upscaling.
我们推测环境微生物群落包含多种细菌,这些细菌能产生尚未被表征的抗菌化合物(AMC),这些化合物有可能用于控制病原体。从土壤和食品堆肥样本中分离出600多种细菌菌株,并基于对多种食品和植物病原体的抑制试验,选择了68种具有抗菌活性的生防细菌进行进一步研究。为了进一步表征生物活性化合物,建立了一种新方法,该方法利用液体培养中的活病原体刺激细菌在细菌上清液中产生大量AMC。采用肽凝胶电泳微生物抑制试验同时实现抗菌肽的大小分离。然后通过串联质谱对15种潜在的生物活性肽进行进一步表征,揭示了冷休克蛋白和50S核糖体蛋白。为了鉴定非肽类AMC,通过高效液相色谱(HPLC)随后进行气相色谱/质谱联用(GC/MS)分析细菌上清液。在鉴定出的14种生物活性化合物中,3-异丁基六氢吡咯并[1,2-a]吡嗪-1,4-二酮和2-乙酰基-3-甲基八氢吡咯并[1,2-a]哌嗪-1,4-二酮被鉴定为新的AMC。我们的工作表明,微生物在面临来自其他微生物的威胁时,抗菌化合物的产生会增强,并且这种方法可以迅速推动具有扩大规模潜力的新型抗菌剂的开发。